Data as of 12:45pm ET
| +0.01 / +0.16%|
The 3 analysts offering 12-month price forecasts for PROLOR Biotech Inc have a median target of 8.00, with a high estimate of 8.00 and a low estimate of 7.00. The median estimate represents a +24.61% increase from the last price of 6.42.
The current consensus among 3 polled investment analysts is to Buy stock in PROLOR Biotech Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.